CORRECTION: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.
News provided byACCESSWIRE
Sep 18, 2023, 10:55 AM ET
Correcting ticker in the release that was issued earlier today.
NOTE: AN EARLIER VERSION OF THIS PRESS RELEASE INCORRECTLY IDENTIFIED THE TICKER FOR MEI PHARMA, INC. AS "MEI'-- ABBOTT COOPER PLLC IS NOT CONDUCTING AN INVESTIGATION INTO METHODE ELECTRONICS, INC. AND REGRETS ANY CONFUSION THIS ERROR MAY HAVE CAUSED
STAMFORD, CT / ACCESSWIRE / September 18, 2023 / Abbott Cooper PLLC is investigating MEI Pharma, Inc. (Nasdaq:MEIP) ("MEI" or the "Company") on behalf of the Company's investors.
The investigation seeks to determine the extent to which MEI's stockholders have been injured as a result of any efforts by MEI's board of directors to entrench themselves and avoid being held accountable by MEI's true owners.
MEI stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing email@example.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders' rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
Abbott Cooper PLLC
J. Abbott R. Cooper, Esq.
Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE: Abbott Cooper PLLC
View source version on accesswire.com:
NOTE: This content is not written by or endorsed by "KRBC/KTAB", its advertisers, or Nexstar Media Inc.